Anil Tulpule

6.6k total citations · 2 hit papers
93 papers, 4.6k citations indexed

About

Anil Tulpule is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Anil Tulpule has authored 93 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 42 papers in Pathology and Forensic Medicine and 31 papers in Genetics. Recurrent topics in Anil Tulpule's work include Lymphoma Diagnosis and Treatment (42 papers), Viral-associated cancers and disorders (38 papers) and Chronic Lymphocytic Leukemia Research (30 papers). Anil Tulpule is often cited by papers focused on Lymphoma Diagnosis and Treatment (42 papers), Viral-associated cancers and disorders (38 papers) and Chronic Lymphocytic Leukemia Research (30 papers). Anil Tulpule collaborates with scholars based in United States, Canada and Singapore. Anil Tulpule's co-authors include Charles E. Myers, Kenneth H. Cowan, Gerald Batist, Birandra K. Sinha, Byron M. Espina, Alexandra M. Levine, Aspandiar G. Katki, Parkash S. Gill, A Levine and Bharat N. Nathwani and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Anil Tulpule

89 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

1986 724 citations Anil Tulpule et al. profile →
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

2010 663 citations Wyndham H. Wilson, Owen A. O’Connor et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anil Tulpule United States	33	2.6k	1.7k	1.6k	745	433	93	4.6k
James M. Pluda United States	43	2.0k 0.8×	887 0.5×	2.3k 1.4×	743 1.0×	324 0.7×	87	6.0k
Jean L. Grem United States	41	3.0k 1.2×	580 0.3×	1.8k 1.1×	396 0.5×	208 0.5×	168	5.9k
Emmanuel Gyan France	29	1.0k 0.4×	1.1k 0.7×	577 0.4×	794 1.1×	286 0.7×	164	2.7k
Michelle A. Rudek United States	48	2.5k 1.0×	545 0.3×	3.8k 2.4×	602 0.8×	210 0.5×	239	7.2k
Chaim Shustik Canada	29	1.9k 0.7×	1.1k 0.6×	2.0k 1.2×	1.0k 1.4×	329 0.8×	74	4.5k
Masashi Bando Japan	26	2.5k 1.0×	605 0.4×	2.0k 1.3×	190 0.3×	174 0.4×	139	6.7k
Fritz Offner Belgium	40	2.3k 0.9×	2.7k 1.6×	1.3k 0.8×	2.0k 2.7×	298 0.7×	236	6.1k
E Frei United States	42	2.2k 0.9×	885 0.5×	1.8k 1.1×	635 0.9×	477 1.1×	104	6.1k
Sung‐Soo Yoon South Korea	35	1.5k 0.6×	733 0.4×	1.6k 1.0×	637 0.9×	166 0.4×	342	4.2k
F Zintl Germany	37	1.3k 0.5×	415 0.2×	1.2k 0.7×	397 0.5×	314 0.7×	161	4.1k

Countries citing papers authored by Anil Tulpule

Since Specialization

Citations

This map shows the geographic impact of Anil Tulpule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil Tulpule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil Tulpule more than expected).

Fields of papers citing papers by Anil Tulpule

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil Tulpule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil Tulpule. The network helps show where Anil Tulpule may publish in the future.

Co-authorship network of co-authors of Anil Tulpule

This figure shows the co-authorship network connecting the top 25 collaborators of Anil Tulpule. A scholar is included among the top collaborators of Anil Tulpule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil Tulpule. Anil Tulpule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilson, Wyndham H., Owen A. O’Connor, Myron S. Czuczman, et al.. (2010). Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. The Lancet Oncology. 11(12). 1149–1159. 663 indexed citations breakdown →

Cianfrocca, Mary, Charles Lee, Jamie Von Roenn, et al.. (2010). Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcoma. Cancer. 116(16). 3969–3977. 109 indexed citations

Robinson, Katherine, Michael E. Williams, Richard H. van der Jagt, et al.. (2008). Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma. Journal of Clinical Oncology. 26(27). 4473–4479. 250 indexed citations

Tulpule, Anil, Byron M. Espina, Nancy E.J. Berman, et al.. (2006). Phase I/II Trial of Nonpegylated Liposomal Doxorubicin, Cyclophosphamide, Vincristine, and Prednisone in the Treatment of Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma. Clinical Lymphoma & Myeloma. 7(1). 59–64. 19 indexed citations

Straus, David J., Marcia A. Testa, Brenda Sarokhan, et al.. (2006). Quality‐of‐life and health benefits of early treatment of mild anemia. Cancer. 107(8). 1909–1917. 45 indexed citations

Tulpule, Anil. (2005). Multidrug resistance in AIDS-related lymphoma. Current Opinion in Oncology. 17(5). 466–468. 7 indexed citations

Levine, Alexandra M., Saeed Sadeghi, Byron M. Espina, Anil Tulpule, & Bharat N. Nathwani. (2002). Characteristics of indolent non‐hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection. Cancer. 94(5). 1500–1506. 16 indexed citations

Tulpule, Anil, Jerome E. Groopman, M. Wayne Saville, et al.. (2002). Multicenter trial of low‐dose paclitaxel in patients with advanced AIDS‐related Kaposi sarcoma. Cancer. 95(1). 147–154. 110 indexed citations

Levine, A & Anil Tulpule. (2001). Clinical aspects and management of AIDS-related Kaposi's sarcoma. European Journal of Cancer. 37(10). 1288–1295. 62 indexed citations

10.

Levine, A, Philip H. Li, Tony Cheung, et al.. (2000). Chemotherapy Consisting of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine With Granulocyte–Colony-Stimulating Factor in HIV-Infected Patients With Newly Diagnosed Hodgkin's Disease: A Prospective, Multi-institutional AIDS Clinical Trials Group Study (ACTG 149). JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(5). 444–450. 70 indexed citations

11.

Tulpule, Anil, Gary J. Schiller, Myung Lee, et al.. (1998). Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma. Cancer. 83(11). 2370–2376. 18 indexed citations

12.

Tulpule, Anil & Samuel C. Matheny. (1998). AIDS-RELATED MALIGNANCIES. Primary Care Clinics in Office Practice. 25(2). 473–482. 3 indexed citations

13.

Tulpule, Anil, Rex Yung, J Wernz, et al.. (1998). Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma.. Journal of Clinical Oncology. 16(10). 3369–3374. 39 indexed citations

14.

Cai, Jie, et al.. (1997). Treatment of epidemic (AIDS-related) Kaposi's sarcoma. Current Opinion in Oncology. 9(5). 433–439. 14 indexed citations

15.

Tulpule, Anil, Bharat Joshi, Byron M. Espina, et al.. (1997). Interleukin-4 in the treatment of AIDS-related Kaposi’s sarcoma. Annals of Oncology. 8(1). 79–83. 26 indexed citations

16.

Levine, A, Anil Tulpule, Lawrence D. Kaplan, et al.. (1997). Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial.. Journal of Clinical Oncology. 15(3). 1094–1103. 34 indexed citations

17.

Gill, Parkash S., Yanto Lunardi-Iskandar, Stan G. Louie, et al.. (1996). The Effects of Preparations of Human Chorionic Gonadotropin on AIDS-Related Kaposi's Sarcoma. New England Journal of Medicine. 335(17). 1261–1267. 90 indexed citations

18.

Muggia, Franco M., Anil Tulpule, Anastassios D. Retzios, et al.. (1994). Intraperitoneal 5-fluoro-2′-deoxyuridine with escalating doses of leucovorin: Pharmacology and clinical tolerance. Investigational New Drugs. 12(3). 197–206. 5 indexed citations

19.

Sharma, B, et al.. (1971). Comparison of Adrenergic Beta-blocking Drugs in Angina Pectoris. BMJ. 3(5767). 152–155. 16 indexed citations

20.

Tulpule, Anil, et al.. (1964). OBSERVATIONS ON THE AETIOLOGY AND PROGNOSIS OF TETANUS. BASED ON A STUDY OF 1852 CASES.. PubMed. 42. 203–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact